Cargando…

Interleukin-4 in the Generation of the AERD Phenotype: Implications for Molecular Mechanisms Driving Therapeutic Benefit of Aspirin Desensitization

Aspirin-exacerbated respiratory disease (AERD) is explained in part by over-expression of 5-lipoxygenase, leukotriene C4 synthase (LTC(4)S) and the cysteinyl leukotriene (CysLT) receptors (CysLT1 and 2), resulting in constitutive over-production of CysLTs and the hyperresponsiveness to CysLTs that o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steinke, John W., Payne, Spencer C., Borish, Larry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259477/ https://www.ncbi.nlm.nih.gov/pubmed/22262978 http://dx.doi.org/10.1155/2012/182090

Ejemplares similares

Aspirin challenge and desensitization in patients with suspected AERD in Qatar
por: Khalil, Sally, et al.
Publicado: (2022)

The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD)()
por: Spies, Jonas Willian, et al.
Publicado: (2015)

The Role of Mast Cells in Aspirin-Exacerbated Respiratory Disease (AERD) Pathogenesis: Implications for Future Therapeutics
por: Kuruvilla, Merin E, et al.
Publicado: (2020)

Is endoscopic sinus surgery sufficient to modify the evolution of adult AERD? Aspirin desensitization as a maintenance factor: systematic review
por: Conti, Diego M., et al.
Publicado: (2023)

AERD: Quo Vadis?
por: Bosso, John V.
Publicado: (2020)

285 Clinics and Laboratory Characteristics of Asthmatic Patients with Aspirin Exacerbated Respiratory Disease (AERD)
por: Roso, Marice Guterrez, et al.
Publicado: (2012)

Th2 cytokines and asthma — Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists
por: Steinke, John W, et al.
Publicado: (2001)

Pathomechanisms of AERD—Recent Advances
por: Lyly, Annina, et al.
Publicado: (2021)

Pathogenic Mechanisms and In Vitro Diagnosis of AERD
por: Schäfer, Dirk, et al.
Publicado: (2012)

The SNP rs3128965 of HLA-DPB1 as a Genetic Marker of the AERD Phenotype
por: Kim, Seung-Hyun, et al.
Publicado: (2014)

Functional Analysis of -351 Interleukin-9 Promoter Polymorphism Reveals an Activator Controlled by NF-κB
por: Early, S Brandon, et al.
Publicado: (2009)

Aspirin Desensitization: Implications for Acetylsalicylic Acid-Sensitive Pregnant Women
por: Benito-Garcia, Filipe, et al.
Publicado: (2021)

Aspirin-exacerbated Respiratory Disease: A Syndrome of Mast Cell–mediated PgD2 Overproduction
por: Borish, Larry
Publicado: (2019)

Endoscopic outcomes in patients with AERD treated with topical antibiotics and intranasal corticosteroids
por: Martinez-Paredes, Jhon F., et al.
Publicado: (2022)

Aspirin desensitization for urgent endovascular treatment of the aneurysm
por: Aguiar, Rita, et al.
Publicado: (2014)

Patient characterization and predictors of aspirin desensitization response
por: Cheong, Zuhui, et al.
Publicado: (2021)

Differences in men and women suffering from CRSwNP and AERD in quality of life
por: Bartosik, Tina J., et al.
Publicado: (2020)

378 Aspirin Desensitization Treatment: A Case Report
por: Alvarez, Mirta, et al.
Publicado: (2012)

Clinical and Immunological Efficacy of Aspirin Desensitization in Nasal Polyp Patients with Aspirin-Exacerbated Respiratory Disease
por: Mortazavi, Negar, et al.
Publicado: (2017)

The impact of endoscopic sinus surgery and aspirin desensitization on psychological burden in aspirin-exacerbated respiratory disease
por: Locke, Tran, et al.
Publicado: (2020)

Description of 3 Cases in Vietnam of Aspirin Desensitization in Patients With Coronary Artery Disease and Coexisting Aspirin Hypersensitivity
por: Van Nguyen, Dinh, et al.
Publicado: (2012)

Systematic review of outcomes for endoscopic sinus surgery and subsequent aspirin desensitization in aspirin-exacerbated respiratory disease
por: Ryan, Lindsey, et al.
Publicado: (2020)

Primary Cutaneous Vasculitis Masquerading as Drug Induced following Aspirin Desensitization
por: Al-Nesf, Maryam Ali, et al.
Publicado: (2013)

One- versus 2-day aspirin desensitization in aspirin exacerbated respiratory disease: A quality improvement project
por: Gansert, Emily, et al.
Publicado: (2023)

Eosinophils in antiviral immunity and (perhaps) a benefit of having asthma during the SARS-CoV2 pandemic
por: Eid, Ryan, et al.
Publicado: (2021)

Lung function and side effects of Aspirin desensitization: a real world study
por: Turpeinen, Heikki, et al.
Publicado: (2021)

Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
por: Van Broeck, Dorien, et al.
Publicado: (2023)

Endoscopic sinus surgery and aspirin desensitization improve otologic-specific SNOT-22 scores
por: Naples, James G., et al.
Publicado: (2020)

Aspirin-Exacerbated Respiratory Disease Requiring Desensitization Prior to Planned Percutaneous Catheterization Intervention
por: Landa, Eric, et al.
Publicado: (2022)

Aspirin desensitization in nonsteroidal anti-inflammatory exacerbated respiratory disease: The first prospective cohort in Chile
por: Siña, María Josefina, et al.
Publicado: (2023)

Immune Surveillance by Rhinovirus-Specific Circulating CD4(+) and CD8(+) T Lymphocytes
por: Steinke, John W., et al.
Publicado: (2015)

Critical Overview on the Benefits and Harms of Aspirin
por: Kwok, Chun Shing, et al.
Publicado: (2010)

Aspirin for the next generation
por: Henderson, Nick, et al.
Publicado: (2013)

Use of mepolizumab in adult patients with cystic fibrosis and an eosinophilic phenotype: case series
por: Zhang, Lijia, et al.
Publicado: (2020)

Azathioprine and aspirin in treatment of childhood primary arterial stroke: therapeutic benefits and side effects
por: Alhaboob, A, et al.
Publicado: (2012)

Therapeutic benefits and side effects of Azathioprine and Aspirin in treatment of childhood primary arterial stroke
por: Alhaboob, Ali A, et al.
Publicado: (2014)

Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta
Publicado: (1995)

Interleukin-10 is increased in successful drug desensitization regardless of the hypersensitivity reaction type
por: Gelincik, Aslı, et al.
Publicado: (2019)

Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances
por: Steinke, John W, et al.
Publicado: (2016)

Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions
por: Klaewsongkram, Jettanong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6uuetfr7npdbhj4vp1s4h2v2gu